CanadianInsider reported two transactions on January 30, 2020 for insider transactions. Erik Paul Pederson acquired 15000 common shares in the public market at average price of $0.325. Ryan Delmoral Ko also acquired 9500 shares at $0.34 on the same day in the public market transaction.
Nextleaf Solutions Granted Health Canada Cannabis Research License
The newly-granted licence allows Nextleaf Labs to conduct a number of research and development (“R&D”) activities, including stability trials on the Company’s nanoemulsified water soluble THC and CBD formulations. “With a sub 10 minute onset time and no hangover symptoms, we are excited to continue to validate our intellectual property by scaling our cannabis-infused beverage technology from laboratory to commercial scale,” said Paul Pedersen, CEO of Nextleaf Solutions.
About Nextleaf Solutions
OILS is developing disruptive intellectual property for industrial-scale extraction, and purification of cannabinoids. The Company owns a portfolio of 12 issued patents pertaining to the production of high-purity, cannabinoid-rich distillate, the key ingredient used in the manufacturing of standardized THC and CBD based products. Nextleaf Solutions commercializes its intellectual property portfolio through IP licensing, and supplying THC and CBD oils through Nextleaf Labs, a Health Canada licenced Standard Processor.
Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.